Second generation 4-(4-methyl-1H-indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile PKCθ inhibitors
Authors:
- Diane H. BoschelliDBDiane H. Boschelli
- Julie LeeJLJulie Lee
- Xiaoke YangXYXiaoke Yang
- Divya ChaudharyDCDivya Chaudhary
- 1 February 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (3) , 766-769
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The PKC inhibitor AEB071 may be a therapeutic option for psoriasisJournal of Clinical Investigation, 2008
- 2-Alkenylthieno[2,3-b]pyridine-5-carbonitriles: Potent and selective inhibitors of PKCθBioorganic & Medicinal Chemistry Letters, 2008
- Synthesis and PKCθ inhibitory activity of a series of 4-(indol-5-ylamino)thieno[2,3-b]pyridine-5-carbonitrilesBioorganic & Medicinal Chemistry Letters, 2008
- Protein kinase C theta (PKCθ): A key player in T cell life and deathPharmacological Research, 2007
- Discovery of potent and selective PKC-θ inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Enzastaurin hydrochlorideDrugs of the Future, 2007
- RuboxistaurinDrugs of Today, 2006
- Protein Kinase C θ Is Critical for the Development of In Vivo T Helper (Th)2 Cell But Not Th1 Cell ResponsesJournal of Experimental Medicine, 2004
- Protein kinase Cδ controls self-antigen-induced B-cell toleranceNature, 2002
- Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient miceImmunity, 1995